Overview

Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

Status:
Terminated

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

Phase:

Phase 3

Details

Lead Sponsor:

Zensun Sci. & Tech. Co., Ltd.